Close Menu

NEW YORK (GenomeWeb) – FDA Commissioner and personalized medicine champion Scott Gottlieb announced he will resign as the head of the agency in a month. 

In a letter to HHS Secretary Alex Azar, Gottlieb highlighted his efforts to modernize the development process for novel medical technologies, gene therapies, and targeted treatments as among his accomplishments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.